Last Applicant/ Owned by
Summit Therapeutics Inc.
One Broadway, 14th FloorCambridge, MA 02142
US
Serial Number
2055575 filed on 2th Oct 2020
Trademark usage description
pharmaceutical preparations for treatment of clostridioides difficile infection; pharmaceutical compositions; pharmaceutical formulations; antibiotics Read More11
2055575
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 6th May 2025 | Agent Changed |
Submitted for opposition 14 on 14th Apr 2025 | Default Notice Sent |
Submitted for opposition 22 on 25th Sept 2024 | Search Recorded |
Submitted for opposition 20 on 25th Sept 2024 | Examiner's First Report |
Submitted for opposition 287 on 21st Jun 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 2th Oct 2020 | Filed |
Submitted for opposition 1 on 2th Oct 2020 | Created |
Submitted for opposition 31 on 2th Oct 2020 | Formalized |